Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Aug 25, 2026, 4:00 PM EDT
1.130
+0.020 (1.80%)
After-hours: Aug 25, 2026, 7:30 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $143.53 million as of August 25, 2026. Its market cap has decreased by -37.49% in one year.
Market Cap
143.53M
Enterprise Value
139.98M
1-Year Change
-37.49%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has decreased from $145.96M to $143.53M, a decrease of -1.66%. That is a compound annual growth rate of -0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 143.53M | -18.93% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 157.27M |
| OnKure Therapeutics | 155.91M |
| Outlook Therapeutics | 155.81M |
| Connect Biopharma Holdings | 154.29M |
| Unicycive Therapeutics | 152.37M |
| LENZ Therapeutics | 146.73M |
| Indaptus Therapeutics | 145.90M |
| Equillium | 138.23M |